Skip to main content
. 2011 Mar 21;34(4):910–915. doi: 10.2337/dc10-1922

Table 2.

ORs and 95% CI of PD according to baseline diabetes status and disease duration*

Diabetes
Diabetes duration (years)
No Yes None <10 ≥10 P for trend
All Parkinson diagnoses since 1995
 All participants
  Number of PD patients 1,393 172 1,393 88 66
  OR (95% CI) 1.0 1.41 (1.20–1.66) 1.0 1.11 (0.89–1.38) 1.75 (1.36–2.25) <0.0001
 Excluding participants with stroke, heart disease, cancers, and poor/fair health
  Number of PD patients 952 79 952 40 30
  OR (95% CI) 1.0 1.34 (1.06–1.69) 1.0 1.00 (0.73–1.38) 1.80 (1.25–2.60) 0.008
Parkinson diagnoses between 1995 and 1999
 All participants
  Number of PD patients 465 52 465 25 23
  OR (95% CI) 1.0 1.31 (0.97–1.75) 1.0 0.97 (0.64–1.45) 1.85 (1.21–2.83) 0.02
 Excluding participants with stroke, heart disease, cancers, and poor/fair health
  Number of PD patients 328 27 328 12 12
  OR (95% CI) 1.0 1.34 (0.90–2.00) 1.0 0.87 (0.49–1.56) 2.12 (1.18–3.78) 0.05
Parkinson diagnosis after 2000
 All participants
  Number of PD patients 928 120 928 63 43
  OR (95% CI) 1.0 1.46 (1.20–1.77) 1.0 1.18 (0.91–1.53) 1.70 (1.25–2.31) 0.001
 Excluding participants with stroke, heart disease, cancers, and poor/fair health
  Number of PD patients 624 52 624 28 18
  OR (95% CI) 1.0 1.33 (1.00–1.78) 1.0 1.07 (0.73–1.56) 1.64 (1.02–2.63) 0.06

*Adjusting for age, sex, race, education, smoking, coffee, BMI, and physical activity. The numbers of participants without PD for the overall analyses were 265,658 (no diabetes), 21,439 (diabetes), 14,280 (diabetes <10 years), and 6,255 (diabetes duration ≥10 years). For the analysis excluding stroke, heart disease, cancers, and poor/fair health, the numbers were 203,299, 11,393, 7,878, and 3,030, respectively.